| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |